Balkwill F - Search Results

1

Tumor necrosis factor or tumor promoting factor?

Balkwill F. Balkwill F. Cytokine Growth Factor Rev. 2002 Apr;13(2):135-41. doi: 10.1016/s1359-6101(01)00020-x. Cytokine Growth Factor Rev. 2002. PMID: 11900989 Review. No abstract available.

2

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons.

Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W. Balkwill FR, et al. Cancer Res. 1986 Aug;46(8):3990-3. Cancer Res. 1986. PMID: 2425938

3

Tumour necrosis factor. Improving on the formula.

Balkwill F. Balkwill F. Nature. 1993 Jan 21;361(6409):206-7. doi: 10.1038/361206a0. Nature. 1993. PMID: 8380903 No abstract available.

4

Inflammation and cancer: back to Virchow?

Balkwill F, Mantovani A. Balkwill F, et al. Lancet. 2001 Feb 17;357(9255):539-45. doi: 10.1016/S0140-6736(00)04046-0. Lancet. 2001. PMID: 11229684 Review.

5

Cancer and inflammation: implications for pharmacology and therapeutics.

Balkwill F, Mantovani A. Balkwill F, et al. Clin Pharmacol Ther. 2010 Apr;87(4):401-6. doi: 10.1038/clpt.2009.312. Epub 2010 Mar 3. Clin Pharmacol Ther. 2010. PMID: 20200512 Review.

6

Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust.

Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Orsulic S, Smyth J. Balkwill F, et al. Eur J Cancer. 2003 Sep;39(13):1818-27. doi: 10.1016/s0959-8049(03)00511-2. Eur J Cancer. 2003. PMID: 12932658

7

A cytokine profile of normal and malignant ovary.

Burke F, Relf M, Negus R, Balkwill F. Burke F, et al. Among authors: balkwill f. Cytokine. 1996 Jul;8(7):578-85. doi: 10.1006/cyto.1996.0077. Cytokine. 1996. PMID: 8891439

8

Interferons and cytokines on a grand scale.

Balkwill F, Pitha PM. Balkwill F, et al. Cytokine Growth Factor Rev. 1997 Mar;8(1):91-5. doi: 10.1016/s1359-6101(96)00051-2. Cytokine Growth Factor Rev. 1997. PMID: 9174665

9

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F. Moore RJ, et al. Among authors: balkwill f. Nat Med. 1999 Jul;5(7):828-31. doi: 10.1038/10552. Nat Med. 1999. PMID: 10395330

10

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.

Philip PA, Rea D, Thavasu P, Carmichael J, Stuart NS, Rockett H, Talbot DC, Ganesan T, Pettit GR, Balkwill F, et al. Philip PA, et al. Among authors: balkwill f. J Natl Cancer Inst. 1993 Nov 17;85(22):1812-8. doi: 10.1093/jnci/85.22.1812. J Natl Cancer Inst. 1993. PMID: 8230261 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results